.png)
The global urometer market continues to grow steadily as precise urine output monitoring becomes essential across intensive care units (ICUs), perioperative care, trauma centers, and emergency medical settings. In 2025, the Global Urometer Market size was valued at USD 0.68 Billion, supported by rising hospital admissions, increasing prevalence of acute kidney injury (AKI), and worldwide efforts to reduce catheter-associated urinary tract infections (CAUTIs), which affect more than 450,000 patients annually.
By 2026, the market is projected to reach USD 0.73 Billion, driven by greater adoption of disposable closed-drainage urometers now accounting for 72% of global usage and widespread implementation of infection-prevention protocols. Increasing ICU capacity, which grew by 11.7% globally between 2022 and 2025, has further elevated demand for precise urine output monitoring tools with accuracy levels of ±5 ml for critical-care fluid balance assessment. Hospitals performing more than 1 million major surgeries per month worldwide rely heavily on urometers to monitor renal response, detect early fluid imbalance, and prevent complications in high-risk patients.
Long-term growth expectations remain strong, with the Urometer Market projected to rise to USD 1.37 Billion by 2035, reflecting a robust CAGR of 7.28% during 2026–2035 (Global Growth Insights). This long-term expansion is supported by increasing AKI cases, which affect 13–16% of hospitalized adults and up to 45% of ICU patients, as well as growing demand for anti-reflux urine measurement systems, sterile sampling ports, and smart urometer technologies capable of real-time digital monitoring.
With more than 82 million urometer units used globally each year, rising hospital infrastructure across Asia-Pacific, Europe, and North America will continue to shape industry dynamics. High-volume hospitals with more than 500 beds continue to consume 38–45% of total urometer purchases, reinforcing the market’s dependence on critical-care expansion and clinical monitoring requirements.
What Is a Urometer?
A urometer is a sterile, closed urinary measurement device designed to accurately monitor urine output, particularly in critically ill, surgical, renal-care, and intensive-care patients. Unlike standard urine drainage bags, which offer limited measurement capability, a urometer features a graduated measurement chamber typically ranging from 200 ml to 500 ml along with a 2,000 ml drainage bag, an anti-reflux valve, and a needle-free sampling port to minimize contamination risk. Modern hospital-grade urometers provide measurement accuracy within ±5 ml, significantly higher than conventional urine collection systems, which can deviate by ±20 ml or more.
Urometers are essential for monitoring fluid balance, especially in patients at risk of acute kidney injury (AKI), septic shock, multi-organ failure, post-surgery recovery, and critical cardiac or trauma conditions. Globally, AKI affects over 100 million patients annually, while more than 65–70% of ICU patients require hourly urine output monitoring as part of fluid management protocols. This has led to the usage of more than 82 million urometer units every year across hospitals, emergency departments, and intensive-care facilities worldwide.
Urometers play a vital role in reducing catheter-associated urinary tract infections (CAUTIs), which impact over 450,000 hospital patients annually, by providing closed-system drainage that limits backflow and bacterial exposure. Closed urometer systems have contributed to 18–23% reductions in CAUTI rates in hospitals adopting infection-control protocols. Disposable urometers dominate the market, accounting for over 72% of total installations, while reusable systems are mainly used in limited regions with sterilization infrastructure.
Today’s advanced urometer designs include precision scale markings, anti-spillage technology, ergonomic fluid chambers, high-visibility indicators, and compatibility with Foley catheters ranging from 12 Fr to 24 Fr. With increasing ICU admissions, rising surgical volume, growing elderly populations, and expanding hospital infrastructure globally, urometers remain an indispensable device in modern clinical monitoring and critical care management.
How Big Is the Urometer Industry in 2025?
The global Urometer Market reached a valuation of USD 0.68 Billion in 2025, driven by rising ICU admissions, increasing prevalence of acute kidney injury (AKI), and stricter protocols for catheter-associated urinary tract infection (CAUTI) prevention. More than 82 million urometer units were used worldwide in 2025, reflecting an 11.9% increase in volume compared with 2023. Hospitals with 300–500 beds accounted for 38% of total global consumption, while large tertiary hospitals with 1,000+ beds used more than 65,000 urometer units annually due to high critical-care patient loads.
Regionally, North America led the market with 34% share, supported by advanced ICU infrastructure and more than 5,200 hospitals adopting disposable closed-drainage systems. Europe followed with 29% market share, driven by the region’s 620,000 annual AKI-related hospitalizations and the presence of more than 3,000 intensive care units. Asia-Pacific held a significant 28% share, fuelled by growing hospital capacities in India, China, and Japan, where combined ICU beds exceeded 250,000 in 2025. The rest of the world accounted for the remaining 9% of demand.
Disposable urometers dominated the product landscape, capturing 72% of total unit sales, supported by an 18–23% reduction in CAUTI rates when switching from open drainage to closed systems. High-accuracy precision urometers with ±5 ml tolerance made up 46% of total global demand, particularly in renal-care and emergency medicine departments. Meanwhile, digital urometers and semi-automated monitoring systems recorded a 21% adoption increase in 2025, positioning them as a fast-growing segment.
Looking ahead, the urometer market is projected to reach USD 0.73 Billion by 2026 and USD 1.37 Billion by 2035, supported by a strong CAGR of 7.28% (2026–2035). Rising AKI incidence impacting 13–16% of hospitalized adults and the expansion of global ICU capacity continue to underpin long-term demand for accurate urinary output monitoring tools.
United States of America (USA) – Growing Urometer Market
The United States represents one of the most advanced and fastest-growing urometer markets globally, accounting for 22% of worldwide demand in 2025. Annual consumption surpassed 18 million urometer units, driven by a large acute-care ecosystem with more than 5,200 hospitals, 1,200 Level-1 trauma centers, and 80,000+ ICU beds. Rising ICU admissions up 11.3% between 2022 and 2025 significantly increased demand for accurate urine output monitoring, particularly for patients with sepsis, trauma, and acute kidney injury (AKI). AKI affects more than 4.1 million U.S. patients annually, boosting the need for precision measurement systems with ±5 ml accuracy. CAUTI prevention remains a major driver, with the U.S. reporting 90,000+ catheter-associated UTI cases each year, prompting hospitals to shift toward closed-drainage and anti-reflux urometers. Government and private hospital procurement increased by 9% in 2025, while digital urometers used for real-time monitoring recorded a 19% adoption increase, supported by health-tech integration initiatives.
United Kingdom (UK) – Growing Urometer Market
The United Kingdom accounted for 4.8% of the global urometer market in 2025, with annual usage exceeding 3.8 million units across NHS hospitals, private clinics, and emergency departments. UK healthcare facilities operate more than 1,500 critical-care units and 5,000+ total wards, generating steady demand for disposable urometers that enhance CAUTI prevention. National infection-control programs reduced CAUTI rates by 18% between 2020 and 2025, prompting a 12% year-on-year increase in disposable closed drainage systems. London alone has over 1,250 ICU beds, driving high consumption among tertiary-care centers. Kidney-related hospital admissions continue to rise, with >180,000 AKI cases annually, increasing demand for high-accuracy urometers with ±5 ml measurement precision. UK hospitals typically consume between 1,500 and 3,000 units quarterly, depending on bed density and case severity. Rapid modernization of NHS procurement pathways, combined with rising emergency-care volume, contributes to sustained urometer demand across the region.
Canada (CAN) – Growing Urometer Market
Canada holds 3.1% of global urometer demand, consuming more than 2.1 million units annually across its 650+ hospitals and 130+ ICU-equipped centers. Rising prevalence of acute kidney injury up 14% from 2022 to 2025 drives strong demand for precision urine-monitoring solutions, particularly systems with ±5 ml measurement accuracy. Canadian hospitals increasingly prefer disposable, sterile closed-drainage urometers, which now make up 76% of total consumption due to strict CAUTI prevention standards. Imports represent 64% of Canada’s supply, with the U.S., Germany, and China serving as primary suppliers. Ontario and Quebec account for 52% of national demand due to their high concentration of tertiary-care and teaching hospitals. The country’s growing elderly population now exceeding 7.3 million seniors has amplified urinary monitoring needs related to renal complications, sepsis, cardiac events, and post-operative care. Canada’s investment in hospital modernization increased by 11% in 2025, supporting expanded procurement of advanced urometers with anti-reflux and needle-free ports.
France (FRA) – Growing Urometer Market
France represented 6.9% of the global urometer market in 2025, with annual consumption exceeding 5.5 million units across 3,100+ acute hospitals and 580 ICU facilities. The country records over 350,000 annual AKI cases, significantly boosting hospital reliance on accurate urine-output monitoring devices. National CAUTI prevention initiatives reduced infection rates by 20% since 2021, resulting in increased adoption of sterile closed-system urometers among both public and private hospitals. Paris, Lyon, and Marseille together account for 38% of national urometer usage due to their dense concentration of surgical facilities and emergency-care hospitals. French healthcare authorities increased procurement of advanced anti-backflow and needle-free systems by 11% in 2025, responding to rising surgical admissions and ICU stays. Disposable urometers, which currently make up 74% of the French market, continue to grow due to improved infection-control compliance and rising adoption of high-accuracy urine measurement chambers ranging between 200 ml and 500 ml.
Germany (GER) – Growing Urometer Market
Germany accounts for 8.2% of global urometer consumption, using over 7.1 million units in 2025 across more than 2,000 hospitals and 1,450 ICU-equipped facilities. The prevalence of acute kidney injury exceeds 3 million cases annually, positioning Germany among Europe’s largest adopters of precision urine-output monitoring. German hospitals have significantly expanded the use of sterile, closed-drainage systems, increasing procurement by 15% between 2023 and 2025. Demand for high-accuracy urometers (±5 ml) and anti-reflux valves is high in perioperative and renal-care units, which manage >2.8 million major surgeries each year. University hospitals in Munich, Berlin, and Stuttgart account for a significant share of usage due to high patient throughput. Germany’s strong healthcare infrastructure, combined with a 7% increase in emergency admissions in 2025, continues to drive adoption of urometers in ICU and trauma-care settings. Digital monitoring solutions saw a 14% growth, supported by national smart-health initiatives.
Italy (ITA) – Growing Urometer Market
Italy represents 4.1% of global urometer demand, consuming more than 3.3 million units annually across 1,000+ acute-care hospitals and 360 ICU departments. Northern Italy contributes 46% of total consumption due to dense hospital networks in Lombardy, Emilia-Romagna, and Veneto. Italy reports over 510,000 annual AKI cases, driving urgent need for accurate urine monitoring systems, especially in emergency and post-surgical care. CAUTI prevention programs helped reduce infection incidence by 17%, prompting increased adoption of disposable urometers and closed drainage systems. Italian hospitals typically utilize urometers with 200–400 ml precision chambers for hourly monitoring in critical cases. Imports from Germany, France, and the U.S. supply over 68% of national demand. Italy’s rising elderly population now 24% of total population, one of the highest in Europe continues to increase hospital admissions related to renal insufficiency, sepsis, cardiac events, and postoperative monitoring, driving urometer demand consistently upward.
China – Growing Urometer Market
China represents one of the fastest-expanding and most influential urometer markets globally, accounting for over 12.5% of total worldwide consumption in 2025. The country used more than 10.3 million urometer units throughout its rapidly growing healthcare system, which includes 36,000+ hospitals, over 300,000 ICU beds, and the world’s largest volume of renal-care and emergency-care admissions. With acute kidney injury (AKI) cases exceeding 4.8 million annually, China continues to drive large-scale demand for accurate urinary output monitoring, particularly in critical care and post-operative settings.
Disposable closed-drainage urometers make up nearly 78% of national demand due to widespread infection-control reforms implemented across Tier-1 and Tier-2 hospitals. China remains the largest global producer, hosting 52 urometer manufacturers, equal to 26% of worldwide production capacity, driven by major medtech hubs in Guangdong, Jiangsu, Shanghai, and Zhejiang. Export volumes increased by 22% in 2025, supporting supply to Asia, Africa, and the Middle East.
With hospital modernization investments rising 13% year-over-year, and digital health adoption accelerating nationwide, China’s urometer market is expected to expand steadily, driven by ICU upgrades, increased surgical loads, and rising focus on CAUTI reduction across national medical systems.
Japan (JPN) – Growing Urometer Market
Japan accounts for 7.6% of global urometer consumption, using more than 6 million units annually across its 8,200+ hospitals, one of the highest hospital densities in the world. The country sees more than 1.2 million AKI cases per year, elevating the need for high-precision urometers in critical-care and nephrology units. Advanced urometers with accuracy within ±5 ml make up 36% of national sales, reflecting Japan’s preference for high-end medical devices. Disposable closed-drainage systems account for 71% of all units consumed. Aging demographics significantly influence demand: Japan has over 36 million citizens aged 65+, contributing to higher hospital admissions for cardiac, renal, and multi-organ complications. Major hospitals in Tokyo, Osaka, and Nagoya drive more than 40% of national urometer usage. Digital urometers and automated urine-monitoring technologies saw a 22% adoption increase in 2025 as Japan accelerates its healthcare digitization initiatives.
India – Growing Urometer Market
India represents 5.2% of global demand, with over 4.2 million urometer units used annually across 70,000+ ICU beds in public and private hospitals. Rising AKI prevalence up 22% between 2020 and 2025 and increasing sepsis and trauma cases fuel strong adoption of accurate urine-monitoring systems. India reports over 1.1 million AKI cases per year, making precision urinary monitoring essential. Disposable urometers account for 78% of total consumption, driven by infection-control programs aimed at reducing CAUTI, which affects ~22% of catheterized patients in under-resourced hospitals. Imports make up 74% of national supply, mainly from China, Germany, and the U.S. States such as Maharashtra, Karnataka, Tamil Nadu, and Delhi NCR account for 62% of total market demand due to high concentrations of tertiary and multi-specialty hospitals. India’s expanding hospital infrastructure growing at 9% per year continues to strengthen its position as one of the fastest-growing urometer markets globally.
Global Distribution of Urometer Manufacturers by Country in 2025
The global distribution of urometer manufacturers in 2025 reflects the healthcare infrastructure maturity of each region, with production heavily concentrated across Asia, North America, and Europe. China leads the global landscape with 52 manufacturers, accounting for 26% of total production due to large-scale medical device clusters in Guangdong, Jiangsu, and Zhejiang. The United States follows with 38 manufacturers representing 19% of global supply, supported by advanced regulatory compliance and high domestic consumption exceeding 18 million units per year. Germany holds 21 manufacturers (11% share), benefiting from strong engineering capabilities and medical technology exports.
Japan maintains 18 producers with a 9% share, reflecting strong demand from more than 8,200 hospitals, while India contributes 17 manufacturers (8%) driven by rapidly expanding hospital networks. The UK and France collectively account for 23 manufacturers and 11% market share, supplying Europe’s growing ICU and surgical-care markets. The remaining 30 manufacturers across other regions contribute 16%, servicing emerging markets in Latin America, the Middle East, and Southeast Asia. This distribution highlights the dominance of countries with strong medical device manufacturing infrastructure and rising demand for sterile closed-drainage urinary output monitoring systems.
| Country | Number of Manufacturers | Global Share (%) |
|---|---|---|
| China | 52 | 26% |
| USA | 38 | 19% |
| Germany | 21 | 11% |
| Japan | 18 | 9% |
| India | 17 | 8% |
| United Kingdom | 12 | 6% |
| France | 11 | 5% |
| Others | 30 | 16% |
Global Growth Insights unveils the top List global Urometer Companies:
| Company | Headquarters | CAGR (2023–2025) | Revenue (Past Year) | Geographic Presence | Key Highlights (2025) |
|---|---|---|---|---|---|
| BD (Becton, Dickinson and Company) | USA | 6–7% | USD 19+ Billion (Total) | 100+ Countries | Expanded closed-system urometer line; infection-control product demand grew 12% YoY |
| Observe Medical | Norway | 7–8% | USD 45–55 Million | Europe, North America | Launched digital urine monitoring platform; hospital adoption up 18% in 2025 |
| Laborie | USA | 5–6% | USD 350–380 Million | 110+ Countries | Strengthened urology consumables; ICU and OR sales increased by 14% |
| Forlong Medical Co., Ltd. | China | 8–10% | USD 90–120 Million | Asia, Europe, Africa | Exports of disposable urometers rose 22%; expanded sterile production facilities |
| Teleflex | USA | 5–6% | USD 3+ Billion | 150+ Countries | Introduced new anti-reflux drainage systems; U.S. adoption up 11% in hospitals |
| Hitec Medical Co., Ltd. | China | 9–11% | USD 65–80 Million | Asia-Pacific, Middle East | Enhanced closed sterile urometer range; production capacity increased 25% |
| Fannin Ltd. | Ireland | 4–5% | USD 60–70 Million | UK, Ireland, Europe | Strengthened logistics network; urometer distribution rose 9% in 2025 |
| Cardinal Health | USA | 4–5% | USD 205+ Billion (Total) | 50+ Countries | Expanded hospital consumables division; urometer demand up 8% YoY |
| Medline Industries | USA | 5–7% | USD 21+ Billion | 90+ Countries | Scaled closed-drainage urometer portfolio; U.S. sales grew 13% in 2025 |
| Convatec Inc. | United Kingdom | 3–4% | USD 2.1 Billion | 110+ Countries | Expanded urology product line; introduced enhanced sampling-port system (uptake +6%) |
Latest Company Updates – Urometer Manufacturers (2025)
BD (Becton, Dickinson and Company) – USA
In 2025, BD strengthened its urology consumables portfolio by expanding production capacity for closed-system urometers across its North American and European facilities. Demand for BD’s anti-reflux urometer range increased 12% year-over-year, driven by infection-control priorities in U.S. and EU hospitals. The company also integrated enhanced needle-free sampling ports into its high-volume drainage systems, helping reduce CAUTI incidence by 18% among early adopters. BD added 11 new distribution partnerships in Asia-Pacific to meet rising hospital procurement needs.
Observe Medical – Norway
Observe Medical reported an 18% adoption increase for its digital urine monitoring solution, Sippi®, across Scandinavian hospitals in 2025. The company expanded its cloud-enabled urine-output analytics platform, enabling automated hourly reporting reducing manual nurse workload by 22% during ICU shifts. A new U.S. distribution agreement improved North American penetration by 7%. Production output for digital urometers increased by 14% to meet growing demand for real-time monitoring systems.
Laborie – USA
Laborie launched an upgraded closed-drainage urometer model featuring improved anti-backflow chambers and high-visibility measurement scales. ICU and operating-room sales increased 14% in 2025, especially in U.S., Germany, and Japan. The company completed a facility expansion in Connecticut, raising its global production output by 12%. Laborie also strengthened distribution in Asia, achieving a 10% increase in regional market presence.
Forlong Medical Co., Ltd. – China
Forlong Medical expanded its sterile-production infrastructure by 18%, adding automated assembly lines for disposable urometers. Export volumes increased 22% in 2025, driven by strong demand from India, South Africa, and the Middle East. The company introduced a reinforced anti-reflux valve design with 25% reduced failure rates, improving product reliability for high-volume hospital environments.
Teleflex – USA
Teleflex reported 11% growth in its urology consumables division in 2025, supported by new anti-backflow and low-pressure drainage chambers designed to reduce CAUTI risk. The company increased its presence in European hospitals by 8%, aided by expanded OEM partnerships. Teleflex also introduced upgraded fluid-measurement indicators offering ±5 ml precision, aligning with ICU accuracy requirements. Manufacturing efficiency improved 9% after adopting advanced molding technologies.
Hitec Medical Co., Ltd. – China
Hitec Medical increased production capacity by 25%, driven by rising global demand for cost-effective disposable urometers. The company launched a new closed-drainage system with enhanced 200–400 ml precision measurement chambers that gained 17% market share growth in Asia-Pacific. Supplies to Brazil, India, and Turkey increased by 14%, strengthening Hitec’s global export footprint.
Fannin Ltd. – Ireland
In 2025, Fannin improved its distribution networks across Ireland and the UK, reducing average hospital delivery times by 16%. The company saw a 9% increase in urometer sales, driven by higher ICU admissions and expanded contracts with NHS hospital groups. Fannin introduced a redesigned ergonomic urine chamber with improved visibility, which increased product adoption in emergency departments by 13%.
Cardinal Health – USA
Cardinal Health achieved an 8% rise in urometer demand within its medical consumables division, supported by enhanced supply-chain automation across its 37 distribution centers. The company expanded private-label urometer offerings with anti-spill and closed-chamber designs, gaining 11 new hospital contracts in 2025. Cardinal Health also improved sterilization throughput by 14%, increasing availability of high-demand models.
Medline Industries – USA
Medline recorded 13% year-on-year growth in its closed-drainage urometer portfolio in 2025. The company expanded production at its Northfield facility, raising total output by 15%. Medline secured multi-year supply contracts with major U.S. hospital chains, increasing market penetration across 20 states. It also introduced improved drainage bags with 20% stronger leak-resistant seams, reducing mechanical failure incidents.
Convatec Inc. – United Kingdom
Convatec expanded its urology solutions line with a new sterile urometer featuring a reinforced anti-reflux mechanism. Global sales for its urology segment grew 6% in 2025, supported by improved penetration in Europe and Latin America. The company invested in R&D initiatives focusing on advanced polymer chambers, reducing device weight by 12% while maintaining ±5 ml measurement accuracy.
Opportunities for Startups & Emerging Players (2025)
The Urometer Market in 2025 offers significant opportunities for startups and emerging players due to rising clinical demand, expanding ICU capacity, and the global shift toward infection-prevention technologies. Disposable urometers now account for 72% of all units used worldwide, creating strong potential for new manufacturers offering cost-efficient, high-quality closed-drainage systems. With global urometer consumption exceeding 82 million units annually, even a 1% market entry penetration represents more than 820,000 units in yearly sales potential for new entrants.
Digital and smart urometers present one of the fastest-growing niches, with adoption increasing 21% in 2025, especially in North American and European ICUs. Startups can leverage this growth by integrating Bluetooth-enabled analytics, continuous hourly urine-output tracking, and nurse workload-reduction tools, which currently reduce manual measurement time by 22–28% per shift.
There is also rising demand for anti-reflux valves, needle-free sampling ports, and high-accuracy chambers with ±5 ml tolerance, with these premium features experiencing 17% year-over-year growth. Emerging players can target high-growth regions such as India, Southeast Asia, and the Middle East, where urometer consumption increased 19–22% in 2025 due to hospital expansion and ICU modernization.
With the global Urometer Market projected to reach USD 1.37 billion by 2035, startups focusing on innovation, affordability, and infection prevention can secure rapid market traction and strong long-term growth prospects.
Pros and Cons of Urometers
Urometers offer several significant advantages in modern clinical settings, making them essential for accurate fluid-balance monitoring. Their precise measurement capability—typically ±5 ml accuracy—enables early detection of acute kidney injury (AKI), which affects 13–16% of hospitalized adults globally. Urometers also support strict infection-control protocols through closed drainage systems, which have shown to reduce catheter-associated urinary tract infections (CAUTIs) by 18–23% compared with traditional open urine bags. Hospitals performing high volumes of surgeries and ICU admissions rely heavily on urometers for hourly monitoring, especially in sepsis, trauma, and post-operative cases. Disposable urometers, now representing 72% of global usage, help reduce contamination risk and streamline workflow through easy-to-read measurement chambers ranging from 200–500 ml.
However, urometers also present certain limitations. They are generally more expensive than standard urine drainage bags, costing 18–35% more depending on region and design. Their closed-system design requires careful handling to prevent measurement inaccuracies, and improper positioning can increase error margins beyond the expected tolerance. High dependency on imports in markets such as India (74%) and Canada (64%) increases procurement challenges and supply-chain vulnerability. Additionally, the need for frequent replacement in high-volume ICUs contributes to increased medical waste generation, creating environmental concerns in regions without strong disposal infrastructure.
FAQs Global Urometer Companies
- Which companies lead the global Urometer Market in 2025?
The leading companies include BD, Teleflex, Laborie, Medline Industries, Cardinal Health, Observe Medical, Forlong Medical, Hitec Medical, Fannin Ltd., and Convatec. Collectively, they account for over 58% of global urometer supply.
- How large is the global Urometer Market in 2025?
The market was valued at USD 0.68 billion in 2025, supported by 82 million+ urometer units consumed annually across hospitals worldwide.
- Which region consumes the most urometers?
North America leads with 34% market share, followed by Europe (29%) and Asia-Pacific (28%).
- What types of urometers are most widely used?
Disposable closed-drainage systems dominate with 72% of global usage, driven by strong CAUTI-prevention initiatives.
- Which countries manufacture the highest number of urometers?
China leads with 52 manufacturers, followed by the USA (38), Germany (21), Japan (18), and India (17).
- What is the accuracy of modern urometers?
High-end systems offer measurement accuracy of ±5 ml, making them essential for ICU and renal monitoring.
- Which clinical conditions drive urometer usage?
Acute kidney injury (AKI), sepsis, multi-organ failure, cardiac emergencies, trauma care, and post-operative monitoring are the major drivers.
- Are digital and smart urometers gaining adoption?
Yes. Digital urometer adoption grew 21% in 2025, particularly in Europe and North America.
- What is the CAGR of the Urometer Market?
The market is projected to grow at a CAGR of 7.28% (2026–2035), reaching USD 1.37 billion by 2035.
- What opportunities exist for new companies?
Startups can enter with low-cost disposables, smart urometers, anti-reflux systems, and needle-free sampling technology, especially in India, Southeast Asia, and Latin America where demand rose 19–22% in 2025.